NutrigeneAI participated in the academic symposium “Stem Cell Therapies: Roadmap to Clinical Applications”, hosted by BEHM and held on December 12 at The Chinese University of Hong Kong. Representing an industry team focused on vascular regeneration and iPSC clinical translation, NutrigeneAI engaged in cross-disciplinary discussions with experts spanning basic research, clinical practice, GMP manufacturing, CMC processes, and translational development.
The symposium centered on the clinical translation of iPSC and advanced therapy medicinal products (ATMPs), addressing unmet needs in ischemic diseases such as PAD, practical boundaries of iPSC clinical application, and feasible CMC/GMP—including in-hospital GMP—strategies. Through academic sessions and interactive networking, participants developed shared insights into translational challenges and opportunities, laying the groundwork for future collaboration.
